Testing Alzheimer's risks with Neotiv

In this episode, we are talking to Chris Rehse, founder and and CEO of Neotiv. Founded in 2017, neotiv has developed a digital assistant to monitor and aid the memory of patients with Dementia and Alzheimer's and focuses on improving the early detection of these conditions to facilitate efficacy monitoring, new therapies, and early intervention and prevention of brain health. Relevant for medical underwriting and post-purchase prevention and intervention measures, neotiv's medical platform presents cognitive tests to track cognitive changes in memory and visual information over time. The company also focuses on research, diagnostics and drug development for these conditions.